Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial

Methylene blue for intractable pain from oral mucositis related to cancer treatment: a randomized phase 2 clinical trial

Abstract Background Oral mucositis (OM) in patients receiving cancer therapy is thus far not well managed with standard approaches. We aimed to assess the safety and effectiveness of methylene blue (MB) oral rinse for OM pain in patients receiving cancer therapy. Methods In this randomized, single-b...

Full description

Bibliographic Details
Main Authors: Carlos J. Roldan, Billy Huh, Juhee Song, Yago Nieto, Joyce Osei, Thomas Chai, Kent Nouri, Lakshmi Koyyalagunta, Eduardo Bruera
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Medicine
Subjects:
Oral mucositis
Cancer therapy
Methylene blue Oral Rinse
Online Access:https://doi.org/10.1186/s12916-022-02579-8

Internet

https://doi.org/10.1186/s12916-022-02579-8

Similar Items